Skip to content
Nitazoxanide
Alinia (nitazoxanide) is a small molecule pharmaceutical. Nitazoxanide was first approved as Alinia on 2002-11-22. It is used to treat cryptosporidiosis, diarrhea, giardiasis, and protozoan infections in the USA.
Download report
Favorite
COVID-19
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
animal diseasesD000820
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Alinia (generic drugs available since 2020-11-27)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nitazoxanide
Tradename
Company
Number
Date
Products
ALINIARomark Laboratories L.c.N-021497 RX2004-07-21
1 products, RLD, RS
ALINIARomark Laboratories L.c.N-021498 RX2002-11-22
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
aliniaNew Drug Application2021-01-06
nitazoxanideANDA2022-03-31
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
cryptosporidiosisD003457A07.2
diarrheaHP_0002014D003967R19.7
giardiasisDOID_10718D005873A07.1
protozoan infectionsD011528B50-B64
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
P01: Antiprotozoals
P01A: Agents against amoebiasis and other protozoal diseases
P01AX: Other agents against amoebiasis and other protozoal diseases in atc
P01AX11: Nitazoxanide
HCPCS
No data
Clinical
Clinical Trials
92 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.1117152128
Chronic hepatitis cD019698EFO_0004220B18.27218
Coronavirus infectionsD018352EFO_0007224B34.222
Irritable bowel syndromeD043183EFO_0000555K581112
Type 2 diabetes mellitusD003924EFO_0001360E1111
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B2035118
CryptosporidiosisD003457A07.212125
Human influenzaD007251EFO_0007328J11.1245
Hepatic encephalopathyD006501K72.912214
Rotavirus infectionsD0124002113
EnterovirusD00477022
RhinovirusD01222922
GastroenteritisD005759EFO_1001463K52.9212
DiarrheaD003967HP_0002014R19.7112
Hepatitis cD006526B19.21112
Show 13 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver cirrhosisD008103EFO_0001422K74.0112
Chronic hepatitis bD019694EFO_0004197B18.111
PeriodontitisD010518EFO_0000649K05.311
Viral pneumoniaD011024EFO_0007541J12.911
CoronavirusD01793411
Fatty liverD00523411
Alcoholic fatty liverD005235K70.011
Ulcerative colitisD003093EFO_0000729K51111
ColitisD003092EFO_0003872K52.9111
Protozoan infectionsD011528B50-B64111
Show 4 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver diseasesD008107EFO_0001421K70-K7711
Hepatic insufficiencyD04855011
Kidney diseasesD007674EFO_0003086N0811
Renal insufficiencyD051437HP_0000083N1911
Retinal diseasesD012164HP_0000479H35.911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug interactionsD00434711
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNITAZOXANIDE
INNnitazoxanide
Description
Acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester is a carboxylic ester and a member of benzamides. It is functionally related to a salicylamide.
Classification
Small molecule
Drug classantiparasitics (salicylanilide derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1
Identifiers
PDB
CAS-ID55981-09-4
RxCUI31819
ChEMBL IDCHEMBL1401
ChEBI ID
PubChem CID41684
DrugBankDB00507
UNII IDSOA12P041N (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,847 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
11,302 adverse events reported
View more details